Novo Nordisk A/S logo

Novo Nordisk A/S

NONOF | OTC
Chart Builder DCF Calculator
$38.40
+$0.15 (+0.39%)
At close: Sep 24, 2026, 3:54 PM ET
$38.40
$0 (0.00%)
After-hours: Sep 24, 2026, 3:54 PM ET
Fiscal Year
Period Ending
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
FY 2019
Dec 30, 2019
Net Income
100.99B 83.68B 55.53B 47.76B 42.14B 38.95B
Depreciation & Amortization
8.55B 9.41B 7.36B 6.03B 5.75B 5.66B
Stock-Based Compensation
2.29B 2.15B 1.54B 1.04B 823M 363M
Other Working Capital
8.11B -631M 2.63B 2.19B 5M 441M
Other Non-Cash Items
-5.06B 4.92B 6.46B -2.49B -3.4B -4.41B
Deferred Income Tax
26.2B 20.99B 13.54B 11.32B 10.99B 9.6B
Change in Working Capital
-12B -12.25B -5.34B -8.66B -4.35B -3.39B
Operating Cash Flow
120.97B 108.91B 78.89B 55B 51.95B 46.78B
Capital Expenditures
-51.31B -38.9B -14.75B -7.39B -22.08B -11.23B
Cash Acquisitions
-82.16B n/a -7.08B -18.28B -392M -100M
Purchase of Investments
-19.81B -13.29B -9.74B -7.11B n/a -350M
Sales Maturities Of Investments
24.39B 8.29B 6.65B 1.17B 12M 148M
Other Investing Acitivies
-4.15B -13.09B -2.61B -1.05B -16.23B 24M
Investing Cash Flow
-128.9B -43.89B -24.92B -31.61B -22.44B -11.51B
Debt Repayment
73.06B -1.47B -2.41B 15.47B 4.73B -741M
Common Stock Repurchased
-20.18B -29.92B -24.09B -19.45B -16.86B -15.33B
Dividend Paid
-44.14B -31.77B -25.3B -21.52B -20.12B -19.41B
Other Financial Acitivies
n/a n/a n/a n/a n/a n/a
Financial Cash Flow
8.74B -63.16B -51.8B -25.49B -32.24B -35.48B
Net Cash Flow
1.26B 1.74B 1.93B -1.51B -3.19B -218M
Free Cash Flow
69.66B 70.01B 64.13B 47.62B 29.87B 35.55B
Adj. Free Cash Flow
67.37B 67.86B 62.6B 46.58B 29.05B 35.19B
Maintenance CapEx
-26.23B -17.75B -1.52B -2.58B -20.46B -8.08B
Growth CapEx
-25.08B -21.15B -13.23B -4.81B -1.62B -3.16B
Owner Earnings
94.74B 91.16B 77.37B 52.42B 31.49B 38.71B

© 2026 bestshares.com. All rights reserved.